Showing results (341-350 of 824) with videos related to
Sort By:
Pageof 83
Expert Review of Hematology|February 17, 2011
Thalidomide, lenalidomide and bortezomib in the management of newly diagnosed multiple myelomaJacob P Laubach, Robert L Schlossman, Constantine S Mitsiades, et al.International Journal of Oncology|February 1, 2014
IKKβ inhibitor in combination with bortezomib induces cytotoxicity in breast cancer cellsHiromasa Hideshima, Yasuhiro Yoshida, Hiroshi Ikeda, et al.Journal of Cellular Biochemistry|June 5, 2007
Multiple myeloma: a prototypic disease model for the characterization and therapeutic targeting of interactions between tumor cells and their local microenvironmentConstantine S Mitsiades, Nicholas S Mitsiades, Paul G Richardson, et al.Blood|March 19, 2020
YWHAE/14-3-3ε expression impacts the protein load, contributing to proteasome inhibitor sensitivity in multiple myelomaYan Xu, Mariateresa Fulciniti, Mehmet K Samur, et al.Nature Communications|January 3, 2025
Deeper response predicts better outcomes in high-risk-smoldering-myeloma: results of the I-PRISM phase II clinical trialOmar Nadeem, Michelle P Aranha, Robert Redd, et al.Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|June 8, 2001
Tumor Cell Expression of CD59 Is Associated With Resistance to CD20 Serotherapy in Patients With B-Cell MalignanciesSteven P. Treon, Constantine Mitsiades, Nicholas Mitsiades, et al.Current Pharmaceutical Design|September 29, 2012
New insights into the treatment of multiple myeloma with histone deacetylase inhibitorsMichele Cea, Antonia Cagnetta, Marco Gobbi, et al.Blood|February 7, 2002
CD40 activation induces p53-dependent vascular endothelial growth factor secretion in human multiple myeloma cellsYu-Tzu Tai, Klaus Podar, Deepak Gupta, et al.Expert Review of Anticancer Therapy|July 1, 2008
Bortezomib in the front-line treatment of multiple myelomaPaul G Richardson, Constantine Mitsiades, Robert Schlossman, et al.Blood|July 28, 2012
How I treat plasma cell leukemiaNiels W C J van de Donk, Henk M Lokhorst, Kenneth C Anderson, et al.Pageof 83